Bridging the Gaps in Complex Patient Journeys by Enriching Data
Generating insights about patients on specialty therapies through data aggregation and integration can improve patient outcomes
As the number of specialty drugs expands in complex disease areas, such as autoimmune, multiple sclerosis, oncology, and respiratory...
Maximising Tablet Production Through Essential Maintenance Measures
The growing demand for increased tablet quantities and the goal of reducing time to market is putting pressure on manufacturers to produce quality tablets in record time. This calls for the implementation of efficient...
Redefining interoperability in the digital age
From Amazon pharmacy to Apple Health to Epic and Cerner battles to digital drug companions, the state of healthcare interoperability has come alive with digital power. And the COVID-19 pandemic accelerated this ability making...
Applying Agile methodologies in CDMOs
In order to truly help biotech and pharmaceutical companies in their journey from drug development to commercialization, contract development and manufacturing organisations (CDMOs) have begun to incorporate the latest innovations in all aspects of...
Cracking the code for viral vector success
The virotherapy market is a fascinating and fast-paced environment to be in at the moment. From cutting-edge vaccination technologies, to targeted immuno-oncology therapies and potentially curative in-vivo gene therapies, innovation is occurring rapidly and...
Adding Another Dimension to Protein Analysis
How an emerging mass spectrometry technique – TIMS – is revolutionising shotgun proteomics.
High-performance liquid chromatography with time-of-flight mass spectrometry (HPLC–TOFMS) has become a powerful technology for identifying and quantifying proteins. Having said that, it’s...
Meeting Future Global Healthcare Needs with Manufacturing 4.0
The COVID-19 pandemic has brought unprecedented attention to the speed at which drugs are developed, tested, manufactured, and distributed. The need for vaccines and effective treatments for Sars-CoV-2 has meant that the pharmaceutical industry...
Using Execution Systems to Improve Cell and Gene Therapy Processes
In the past decade, cell, and gene therapies (CGT) have shown incredible promise as precision medicines for previously difficult-to-treat diseases, including cancers. The success of approved therapies has been driven by scientific research, as...
Turning 1 into 3: more flexibility in capsule filling
The market for tablets filled into capsules has been growing for years. This dosage form is proving particularly advantageous due to its controlled dissolution behavior. Moreover, the capsules are easier for patients to take....
Advertising Digitally for Rare Disease Clinical Trials in the 21st Century
The ever-increasing number of people using the internet has drastically changed how clinical trials are promoted to patients. Today, clinical trial sponsors and companies working on their behalf can put ads directly in front...